Blogs

Latest Blogs

From Detection to Decision: Risk-Based Immunogenicity Testing

Immunogenicity describes treatment‑induced B‑ and T‑cell responses to therapeutics and represents a major hurdle for drug development, due to the potential impact on patient safety…

The criticality of early detection of pre-eclampsia: New biomarkers

Pre-eclampsia (PE) is a condition that affects up to 8% of pregnancies worldwide.…

Top 3 Biotech Trends in 2024 | Dr. Caroline Beltran 

Dr. Caroline Beltran shares her top 3 trends to watch out for in 2024.…

Top 3 Biotech Trends in 2024 | Dr. Nicholas Woudberg

Read on as Dr. Nicholas Woudberg shares 3 key biotech trends to expect in 2024.…

Bioanalytical Strategies for Cell Therapy Clinical Trials

As we delve into the intricacies of cell therapies and their unique mechanisms of action, the need arises for tailored…
AI robot investigating a disease

AI-assisted pathology for precision medicine: Are we there yet?

Uncovering tissue complexity through spatial biology

Discover how spatial biology is transforming oncology research.…

Quick Links

Talk to our Biomarker Experts